These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1029968)

  • 1. [Differential effects of a new anti-arrhythmia agent (propafenon) on the Purkinje and myocardial activity filaments].
    Bolte HD; Bergmann M; Tebbe U
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1239-42. PubMed ID: 1029968
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of propafenon in myocardial refractoriness].
    Mill JG
    Arq Bras Cardiol; 1981 Jan; 36(1):35-9. PubMed ID: 7271516
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of a new orally active antidysrhythmic agent, Organon 6001, on the cardiac action potential of human ventricular muscle and sheep Purkinje fibres [proceedings].
    Kane KA
    Br J Pharmacol; 1977 Nov; 61(3):457P-458P. PubMed ID: 588815
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers.
    Arnsdorf MF
    J Pharmacol Exp Ther; 1977 Jun; 201(3):689-700. PubMed ID: 577217
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of changrolin on electrophysiological properties of canine Purkinje fibers].
    Gu PK; Wang BY; Chen YL; Shang M; Liu XJ; Jin ZJ
    Zhongguo Yao Li Xue Bao; 1983 Sep; 4(3):170-2. PubMed ID: 6228115
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of propafenone on slow response action potential and the slow inward current of the myocardium].
    Xu YQ; Liu YM; Gao RB; Mei YA; Xu JM
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):138-40. PubMed ID: 2946151
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
    Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres.
    Tamargo J; Delgado C
    Eur J Pharmacol; 1985 Dec; 118(3):331-40. PubMed ID: 4085559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.
    Ledda F; Mantelli L; Manzini S; Amerini S; Mugelli A
    J Cardiovasc Pharmacol; 1981; 3(6):1162-73. PubMed ID: 6173515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-arrhythmic action of beta-adrenergic receptor blocking agents.
    Somani P; Kumakura S
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():367-85. PubMed ID: 4806661
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic effects of ethmozin in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering.
    Dangman KH; Hoffman BF
    J Pharmacol Exp Ther; 1983 Dec; 227(3):578-86. PubMed ID: 6317840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voltage- and rate-dependent depression of Vmax of action potentials by a new antiarrhythmic agent, E-0747, in swine cardiac Purkinje fibers.
    Sawada K; Shoji T; Igarashi T; Hiraoka M
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):51-6. PubMed ID: 2434794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of new antiarrhythmic agent SS-68 on excitation conduction, electrical activity in Purkinje fibers and pulmonary veins: Assessment of safety and side effects risk.
    Bogus SK; Kuzmin VS; Abramochkin DV; Suzdalev KF; Galenko-Yaroshevsky PA
    J Pharmacol Sci; 2017 Mar; 133(3):122-129. PubMed ID: 28325557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of injectable aprindine in dogs, with special reference to the recording of atrial and ventricular monophasic action potentials and the bundle of His electrogram].
    Puech P; Cabasson J; Mellet JM; Guimond C
    Therapie; 1974; 29(5):731-40. PubMed ID: 4462224
    [No Abstract]   [Full Text] [Related]  

  • 17. Inotropic and electrophysiological effects of AB--2, a new antiarrhythmic agent, on isolated cardiac preparations.
    Beresewicz A; Pytkowski B; Sedek G; Zdanowski K
    Pol J Pharmacol Pharm; 1983; 35(3):223-32. PubMed ID: 6651921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrophysiologic characterization of propafenone in man].
    Masini G; Dianda R; Masini M
    G Ital Cardiol; 1984 Apr; 14(4):293-6. PubMed ID: 6735022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.